https://sputnikglobe.com/20210406/ema-still-investigating-apparent-link-between-astrazeneca-covid-19-vaccine-blood-clots-1082554072.html
EMA Still Investigating 'Apparent Link' Between AstraZeneca COVID-19 Vaccine, Blood Clots
EMA Still Investigating 'Apparent Link' Between AstraZeneca COVID-19 Vaccine, Blood Clots
Sputnik International
ROME (Sputnik) - The European Medicines Agency's (EMA) head of health threats and vaccines strategy, Marco Cavaleri, confirmed in an interview with Italy's Il... 06.04.2021, Sputnik International
2021-04-06T11:21+0000
2021-04-06T11:21+0000
2023-04-12T17:09+0000
https://cdn1.img.sputnikglobe.com/img/07e5/04/02/1082516261_26:0:3667:2048_1920x0_80_0_0_17de7ef9751e56aa4d30d605d3aa08c8.jpg
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
newsfeed, europe, european medicines agency, astrazeneca, european union (eu)
newsfeed, europe, european medicines agency, astrazeneca, european union (eu)
EMA Still Investigating 'Apparent Link' Between AstraZeneca COVID-19 Vaccine, Blood Clots
11:21 GMT 06.04.2021 (Updated: 17:09 GMT 12.04.2023) ROME (Sputnik) - The European Medicines Agency's (EMA) head of health threats and vaccines strategy, Marco Cavaleri, confirmed in an interview with Italy's Il Messaggero newspaper the existence of an apparent link between the AstraZeneca COVID-19 vaccine and blood clots and said its causes were being investigated.
"It is increasingly difficult to talk about the absence of a causal relationship between AstraZeneca vaccination and extremely rare cases of blood clots due to low blood platelet count. It is clear that there is a link," Cavaleri said, referring to cases recorded mostly in women under 55 years of age.
The expert stressed that the investigation was far from over and "we still have to understand how this happens."
In March, multiple reports came up about patients experiencing severe complications after receiving the AstraZeneca vaccine. Austria became the first to publicly express concern after a person died from
blood clots within ten days after inoculation and another one was hospitalised with pulmonary embolism.
Following the news, several European states halted the use of AstraZeneca as a precautionary measure until further investigations into the drug's safety were made.
On March 18, the EMA announced that there was no conclusive evidence that AstraZeneca shots could be linked to higher risks of thromboembolic complications.
